Steptoe Secures Patent Litigation Win for Orexo
July 08, 2023
July 08, 2023
MORRISTOWN, New Jersey, July 8 -- Steptoe, a law firm, issued the following news release:
The U.S. District Court for the District of New Jersey ruled in favor of Orexo in its Hatch-Waxman litigation against Sun regarding Zubsolv(R), a novel buprenorphine and naloxone sublingual tablet used for the treatment of opioid dependence.
Following a five-day trial, the district court issued an opinion in favor of Orexo on all issues, finding that Sun infringed Orexo's asserted . . .
The U.S. District Court for the District of New Jersey ruled in favor of Orexo in its Hatch-Waxman litigation against Sun regarding Zubsolv(R), a novel buprenorphine and naloxone sublingual tablet used for the treatment of opioid dependence.
Following a five-day trial, the district court issued an opinion in favor of Orexo on all issues, finding that Sun infringed Orexo's asserted . . .